Related Experiment Video

Updated: Aug 7, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Impaired myocardial contraction in the chronic stage

R Gorlin

    Major Problems in Internal Medicine
    |January 1, 1976
    PubMed

    Insights

    Myocardial ischemia in coronary heart disease causes variable dysfunction, often unrelated to arterial blockage. Understanding and treating these complex mechanical issues requires personalized patient assessment.

    Area of Science:

    • Cardiology
    • Cardiovascular Physiology

    Background:

    • Myocardial ischemia in chronic coronary heart disease presents variable consequences.
    • The correlation between coronary arterial obstruction and myocardial dysfunction is often weak.

    Purpose of the Study:

    • To explore the varied consequences of myocardial ischemia.
    • To analyze the relationship between coronary obstruction and myocardial dysfunction.
    • To discuss diagnostic challenges and therapeutic strategies for ischemia-induced cardiac dysfunction.

    Main Methods:

    • Review of clinical observations and pathological findings in patients with coronary heart disease.
    • Analysis of mechanical lesions resulting from myocardial ischemia.
    • Evaluation of diagnostic approaches and therapeutic planning.

    Main Results:

    • Myocardial dysfunction can be permanent (fibrosis) or transient (acute ischemia).
    • Mechanical lesions include generalized/localized dysfunction, mitral incompetence, and interventricular septal defects.
    • Accurate assessment of individual lesion contribution to patient disability is challenging.

    Conclusions:

    • Therapeutic strategies for ischemia-induced myocardial dysfunction must be individualized.
    • Personalized treatment plans are essential, considering the totality of patient factors.
    • Effective management requires a comprehensive understanding of ischemia's diverse cardiac impacts.

    More Related Videos

    Histological Quantification of Chronic Myocardial Infarct in Rats09:45

    Histological Quantification of Chronic Myocardial Infarct in Rats

    Published on: December 11, 2016

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    Related Concept Videos

    Imbalances in Cardiac Output01:26

    Imbalances in Cardiac Output

    The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
    CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...